CH3
cart Cart (0 items)        
 
Get the latest news in protein methylation research & CH3 BioSystems. more


CH3 BioSystems is a biotechnology company based on an entirely new patent-protected chemical technology designed to identify and commercialize drug and diagnostic candidates.

We manufacture novel molecular tools to help biomedical research better understand cancer and autoimmune, neurodevelopmental, viral and cardiovascular diseases that affect millions of people around the world.

Our long-range vision is to facilitate the creation of diagnostic and pharmaceutical products that are based on the emerging new field of protein methylation biology.
University Commons • 1416 Sweet Home Rd, Suite 8 • Amherst, NY 14228
tel. 716.688.5222 • fax. 866.610.2261 • info@ch3biosystems.com
Copyright © CH3 BioSystems, LLC 2007-2009